From: United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes Mellitus Ann Intern Med. 1996;124(1_Part_2):136-145. doi:10.7326/0003-4819-124-1_Part_2-199601011-00011 Figure Legend: A 9-year comparison of fasting plasma glucose (FPG) levels in the patients of the University Group Diabetes Program (UGDP)[7]who were taking either placebo or variable-insulin doses and in the cohorts of the conventional and insulin therapy groups of the United Kingdom Prospective Diabetes Study (UKPDS) studied for 9 years[33], both analyzed by assignment to therapy.The UGDP measured blood glucose levels and a correction of × 1.1 was used to give equivalent fasting plasma glucose values. The two studies have shown similar deterioration of blood glucose control over 9 years. Date of download: 12/31/2017 Copyright © American College of Physicians. All rights reserved.